Instantly Interpret Free: Legalese Decoder – AI Lawyer Translate Legal docs to plain English

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

# Clearmind Medicine Inc Receives Patent Approval in China for Treatment of Binge Behaviours

Vancouver, Canada –News Direct– Clearmind Medicine Inc

## Clearmind Medicine Inc’s Milestone Achievement

Clearmind Medicine Inc CEO Dr. Adi Zuloff-Shani joined Steve Darling from Proactive to announce a significant milestone for the company: the granting of divisional patent approval by the China National Intellectual Property Administration (CNIPA). This latest patent approval solidifies Clearmind’s patent protection for its flagship molecule and further establishes its extensive intellectual property (IP) protection in the psychedelic space.

Clearmind’s IP portfolio now encompasses fifteen utility patent families, including patents and applications with method of use and composition of matter claims. This includes 24 pending patent applications and 27 granted patents in key jurisdictions such as the US, Europe, China, and India. The company’s robust IP portfolio positions it as a leader in the development of innovative treatments in the psychedelic field.

## Innovative Treatment for Alcohol Use Disorder

Dr. Zuloff-Shani provided insights into Clearmind’s flagship molecule, MEAI, which has shown promise in reducing the desire to consume alcoholic beverages while inducing a slight euphoric, alcohol-like experience. This treatment targets Alcohol Use Disorder, a prevalent condition characterized by an individual’s inability to control their alcohol consumption despite negative consequences. MEAI also holds potential in addressing binge drinking, offering hope for individuals struggling with this harmful addiction.

Clearmind plans to commence clinical trials for alcohol use disorder, expand their IP portfolio, and explore MEAI’s potential in treating obesity. With collaborations with esteemed institutions like Johns Hopkins and Yale, Clearmind aims to revolutionize addiction treatment and offer innovative solutions to societal challenges. Stay tuned for their exciting developments in 2024.

## How AI legalese decoder Can Help

AI legalese decoder can assist Clearmind Medicine Inc in efficiently analyzing and interpreting the complex legal language involved in patent approvals. By utilizing AI technology, the company can streamline the process of managing its extensive IP portfolio and ensure comprehensive protection for its innovative treatments. Additionally, AI legalese decoder can aid in simplifying communication with regulatory authorities and legal entities, enhancing Clearmind’s ability to navigate the intricacies of intellectual property law across different jurisdictions.

### Contact Details
**Proactive North America**
Proactive North America
+1 604-688-8158
[email protected]

View source version on newsdirect.com: [Clearmind Medicine Receives Patent Approval in China for Treatment of Binge Behaviours](https://newsdirect.com/news/clearmind-medicine-receives-patent-approval-in-china-for-treatment-of-binge-behaviours-352970225)

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link